Infect Immun, January 1998, p. 213-217, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Molecular Infectious Diseases Group,
Received 2 September 1997/Returned for modification 17 October
1997/Accepted 31 October 1997
Meningococcal sodC encodes periplasmic copper- and
zinc-cofactored superoxide dismutase (Cu,Zn SOD) which catalyzes the
conversion of the superoxide radical anion to hydrogen peroxide,
preventing a sequence of reactions leading to production of toxic
hydroxyl free radicals. From its periplasmic location, Cu,Zn SOD was
inferred to acquire its substrate from outside the bacterial cell and
was speculated to play a role in preserving meningococci from the action of microbicidal oxygen free radicals produced in the context of
host defense. A sodC mutant was constructed by allelic
exchange and was used to investigate the role of Cu,Zn SOD in
pathogenicity. Wild-type and mutant meningococci grew at comparable
rates and survived equally long in aerobic liquid culture. The mutant
showed no increased sensitivity to paraquat, which generates superoxide within the cytosol, but was approximately 1,000-fold more sensitive to
the toxicity of superoxide generated in solution by the
xanthine/xanthine oxidase system. These data support a role for
meningococcal Cu,Zn SOD in protection against exogenous superoxide. In
experiments to translate this into a role in pathogenicity, wild-type
and mutant organisms were used in an intraperitoneal mouse infection model. The sodC mutant was significantly less virulent. We
conclude that periplasmic Cu,Zn SOD contributes to the virulence of
Neisseria meningitidis, most likely by reducing the
effectiveness of toxic oxygen host defenses.
Neisseria meningitidis is
a major cause of life-threatening bacterial infection throughout the
world, causing a range of conditions from meningitis to fulminant
meningococcal septicemia, with a mortality rate as high as 60% despite
treatment with potent antibiotics and all the resources of modern
intensive care (26). Much attention is accordingly focused
on possibilities for prevention of disease and therefore on
understanding the mechanisms employed by the meningococcus to
facilitate its survival in the course of invasive infection. During
meningococcal disease, organisms continue to proliferate despite
exposure to the microbicidal actions of proteins such as the components
of the complement system and toxic small molecules, including oxygen
free radicals generated by phagocytic cells (for recent reviews, see
reference 12).
Superoxide dismutase (SOD) catalyzes the dismutation of the highly
reactive superoxide radical anion to hydrogen peroxide and molecular
oxygen (37). The removal of superoxide effectively blocks
secondary reactions that otherwise would lead to formation of the
promiscuously reactive hydroxyl radical, which is highly damaging to
all classes of biological macromolecules. Two main classes of SOD have
been identified in bacteria. Metalloenzymes containing manganese or
iron (Mn SOD and Fe SOD, respectively) exhibit close primary sequence
similarity to each other and are found in the bacterial cytosol.
Bacterial copper- and zinc-cofactored SOD (Cu,Zn SOD) is an entirely
distinct enzyme recently described in a wide range of gram-negative
pathogens, where it is found in the periplasm (3, 5, 19, 30-33,
47). A role for periplasmic SOD in the virulence of bacterial
pathogens has been proposed in light of the theoretical capacity of
such an enzyme to dismutate superoxide generated outside the bacterial
cell, for example, in the course of the microbicidal respiratory burst
of phagocytic cells. Evidence in support of such a role has been
conflicting in the case of Brucella abortus (34,
49), but clear evidence has recently been obtained for a role for
Cu,Zn SOD in the virulence of Salmonella typhimurium
(16, 19). Here we report that in N. meningitidis,
as in Salmonella, the periplasmic Cu,Zn SOD protects organisms from the toxic effects of superoxide generated outside the
cell in vitro and that a Cu,Zn SOD mutant shows attenuated virulence in
a mouse model of meningococcal infection.
Bacterial strains and growth conditions.
N.
meningitidis MC12, MC14, MC19, MC50, MC54, C311, and MC58
(50) were generously provided by M. Virji, University of
Reading, Reading, United Kingdom. Neisseria gonorrhoeae MS11
was obtained from B. Robertson, Imperial College School of Medicine at
St. Mary's Hospital, London, United Kingdom. Additional gonococcal isolates and commensal neisseriae were from the collection of C. Ison,
Imperial College School of Medicine at St. Mary's Hospital. Escherichia coli QC779, a sodA sodB mutant
(39), was kindly provided by D. Touati, Jacques Monod
Institut, University of Paris, Paris, France. E. coli SURE
(Stratagene) was used as a host strain for cloning. E. coli
DH5
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results & Discussion
References
(23) was used as a positive control for SOD
expression.
Recombinant DNA methods. Standard methods were used for genomic and plasmid DNA preparation, restriction enzyme analysis, Southern blotting, and cloning (40). Southern hybridizations were carried out under conditions of 80% stringency. Routine cloning was carried out with the cloning vectors pBluescript (Stratagene) and pACYC184 (13). DNA sequencing was carried out by the dideoxy chain termination method (41), with Sequenase version 2.0 (Amersham).
Construction of sodC::bla fusion. To investigate the export of SodC beyond the cytoplasmic membrane, the sodC-containing insert of pJSK205 was recloned into pACYC184. After linearization with BamHI and brief exonuclease digestion, the promotorless, leader peptide-lacking bla gene from pJBS633 (10) was ligated into the digestion product. The bla gene was shown to be in frame with the 5' sequence of sodC.
Construction of the sodC mutant of N. meningitidis. A kanamycin resistance (Kmr) cassette excised from pUC4Kan (Pharmacia) was inserted into the BamHI site of the cloned sodC gene (pJSK207). MC58 was transformed with linearized plasmid as described by Nassif et al. (38). Allelic replacement of the wild-type gene was confirmed by paired Southern hybridization of ClaI-digested chromosomal DNA from kanamycin-resistant transformants, probed with a digoxigenin (DIG)-labelled HindIII/EcoRI fragment from pJSK204 and a DIG-labelled Kmr cassette from pUC4Kan (data not shown).
Preparation of meningococci for studies in liquid culture. Plate-grown N. meningitidis organisms were harvested into phosphate-buffered saline (PBS) and centrifuged at 70 × g for 1 min in order to remove large aggregates. The supernatant suspension was adjusted to 107 CFU/ml with culture medium. Aliquots of 10 ml were placed in 50-ml tubes sealed with a vented cap containing a 0.2-µm-pore-size filter (Becton Dickinson) to ensure that aerobic conditions were maintained. Liquid cultures were incubated at 37°C, with shaking at 180 rpm.
Extraction of bacterial proteins, gel electrophoresis, and detection of SOD activity. In order to detect Cu,Zn SOD activity, meningococci grown overnight on supplemented GC agar or cell pellets from aerobically grown E. coli were suspended in a solution of 50 mM Tris (pH 7.8) (BDH)-1 mM CuSO4 (Tris-CuSO4) and then lysed by three freeze-thaw cycles. Whole-cell extracts (WCE) were separated by nondenaturing polyacrylamide gel electrophoresis (PAGE) under the following conditions: 4.5% (wt/vol) stacking gel (pH 8.3), 10% (wt/vol) separating gel (pH 8.9), and a buffering system essentially the same as that of Davies (15), but with modification of the upper buffer to pH 8.9 with 10 M NaOH. SOD activity was visualized on these gels by the method of Beauchamp and Fridovich (2) as modified by Steinman (45). Cu,Zn SOD activity was inhibited by soaking the gel in 2 mM diethyldithiocarbamate (DEDC) for 30 min prior to activity staining (5). Fe SOD was inhibited by the addition of hydrogen peroxide to a final concentration of 5 mM at the time of incubation with riboflavin, N,N,N',N'-tetramethylethylenediamine and nitroblue tetrazolium (14, 18).
To investigate the expression of meningococcal Cu,Zn SOD during different phases of growth, liquid cultures of MC58 were prepared in Mueller-Hinton broth at an initial density of 107 CFU/ml and incubated at 37°C, with shaking at 180 rpm. A 4-ml sample extracted at 4 h, and 2-ml samples extracted at 8, 12, and 20 h were centrifuged (13,000 × g, 10 min). The pellets were washed with PBS and resuspended in 200 µl of Tris-CuSO4. The cells were lysed by four freeze-thaw cycles, then centrifuged to remove cell debris (13,000 × g, 10 min). Supernatants were assayed for protein by the method of Bradford (8) and were adjusted to equivalent protein concentrations prior to assay for SOD activity.Quantification of growth of N. meningitidis. Meningococcal liquid cultures were studied in triplicate in Mueller-Hinton broth (Difco) supplemented with 2% Vitox, from a starting density of 107 CFU/ml. Over a 48-h period, 20-µl samples were removed from each culture every 2 h, diluted 10-fold serially, and plated on supplemented GC agar for determination of viable CFU. This experiment was performed on two occasions.
Paraquat sensitivity. Paraquat is a redox-cycling agent which readily penetrates cells, including capsulate bacteria, and which, under aerobic conditions, generates a bactericidal flux of superoxide in the cytosol (17, 24). Suspensions of wild-type and sodC mutant N. meningitidis were prepared in PBS, and approximately 300 CFU was plated onto supplemented GC agar containing various concentrations of paraquat. Plates were incubated overnight at 37°C with 5% CO2, and CFU were counted in order to determine survival relative to that on control plates lacking paraquat.
Exposure to X/XO. Meningococcal cultures were studied in GC1 medium (1) containing 100 µM xanthine (X) (Sigma), at an initial density of 107 CFU/ml. In order to generate a superoxide flux, xanthine oxidase (XO) (Sigma) was added at a concentration of 7 mU/ml (sufficient to catalyze reduction of 15 nM ferricytochrome c at a rate of 46 pmol/min) and cultures were incubated at 37°C, with shaking at 180 rpm. Samples (20 µl) were removed at intervals in order to assess viability by serial dilution and plating. Bovine SOD (0.01 U/ml) or bovine catalase (40 U/ml) (both from Sigma) was added to some cultures.
Infection of mice with N. meningitidis. Fifty 6-week-old NIH mice (Harlan) were infected by using the intraperitoneal (i.p.) infection model (28, 35). Bacteria were grown in Mueller-Hinton broth for 4 h, adjusted to the required density with the same medium, and mixed with an equal volume of sterile iron dextran (100 mg of iron/ml; Sigma). Mice received the appropriate challenge dose i.p. in a 0.5-ml suspension, and 24 h later a second i.p. injection, of 0.25 ml of saline containing iron dextran (8 mg of iron/ml), was administered. Deaths were monitored for 4 days after infection. Meningococci of appropriate phenotypes (wild type, kanamycin sensitive; sodC mutant, kanamycin resistant) were recovered from blood, livers, and spleens of dead animals to confirm the cause of death. Results were analyzed by the chi-square statistical test with 1 degree of freedom and continuity correction.
Nucleotide sequence accession number. The sequence of the entire N. meningitidis sodC gene has been deposited in the EMBL database under accession no. AJ001313.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Distribution, nucleotide sequence, and localization of sodC. We have previously cloned a 310-bp PCR product (pJSK204) from within the 3' region of sodC, a gene encoding Cu,Zn SOD in the N. meningitidis serogroup B strain MC58 (32). With this DNA as a probe in Southern hybridization, sodC was found to be present in all strains of a collection of four serogroup B, one serogroup C, and two serogroup A N. meningitidis strains (Fig. 1); these serogroups cause more than 90% of meningococcal disease (20). Eight clinical isolates of N. gonorrhoeae were examined, and no hybridization to pJSK204 was detected. As shared meningococcal and gonococcal genes are predicted to be nearly 90% identical (21, 27), this suggests that sodC is absent from N. gonorrhoeae. In confirmation, no Cu,Zn SOD activity was detectable in total-protein extracts of N. gonorrhoeae MS11 (data not shown). In addition, no hybridization was found to chromosomal DNA from the commensal neisserial species N. lactamica, N. cinerea, N. polysaccharea, and N. mucosa, suggesting that, among neisseriae, sodC is found only in the meningococcus.
|
Expression of meningococcal Cu,Zn SOD. In order to establish that the cloned meningococcal sodC encodes an active Cu,Zn SOD (the gene in Haemophilus influenzae, for example, does not [31]), pJSK205 was transferred into E. coli QC779, a sodA sodB mutant which does not express any detectable SOD in our experimental system during exponential growth. WCE were separated by nondenaturing PAGE and stained to visualize SOD activity (Fig. 2). No SOD activity was detected in exponential-phase cultures of QC779 or of QC779 containing pBluescript. MC58 produced several bands, while QC779 harboring pJSK205 produced a single band of activity, of the same electrophoretic mobility as the uppermost band in wild-type N. meningitidis. In each case this activity was inhibited by 2 mM DEDC, characteristic of Cu,Zn SOD (5). That the remaining bands present in the wild-type meningococcal extract were attributable to isoforms of Fe SOD was confirmed by H2O2 treatment, which selectively abolishes this activity (14).
|
Attenuation of the N. meningitidis sodC mutant. A sodC mutant was constructed by interruption of the coding sequence with a kanamycin resistance cassette. Loss of Cu,Zn SOD activity was confirmed by nondenaturing PAGE (Fig. 3), and the mutant was used to investigate the role of Cu,Zn SOD in meningococcal biology.
|
(i) In vitro. In order to interpret any difference between the pathogenic behaviors of the sodC mutant and the wild type, it was first necessary to demonstrate that Cu,Zn SOD was not essential for normal bacterial growth. During aerobic growth, low levels of superoxide radicals are steadily released into the cytosol in the course of electron transfer to oxygen. The action of cytosolic SOD, in concert with catalase, is accordingly essential for sustained viability under aerobic conditions (11); cytosolic-SOD mutants are clearly defective (17). However, the extracytoplasmic location of Cu,Zn SOD isolates the enzyme from free-radical flux generated in the cytosol, so we anticipated that the sodC mutant phenotype would not differ significantly from the wild-type phenotype in growth and survival in aerobic liquid culture. In a series of experiments, the viability of organisms grown in supplemented Mueller-Hinton broth under aerobic conditions was monitored for periods of up to 48 h. Wild-type and Cu,Zn SOD mutant phenotypes grew at comparable rates (doubling time of approximately 29 min in exponential phase) and reached similar densities (2 × 109 to 5 × 109 CFU/ml) under these conditions. They maintained these densities equally well in stationary phase, up to 38 h. Thereafter, the viable-cell densities dropped rapidly, so that live organisms could no longer be recovered after 48 h. Thus, meningococcal sodC mutants do not appear to be disabled under standard aerobic culture conditions in vitro. In agreement with these observations, Farrant et al. (19) recently demonstrated that wild-type and sodC mutant S. typhimurium grew at comparable rates and survived equally long in aerobic liquid culture. To stress the system further and subject N. meningitidis to an enhanced cytosolic-superoxide flux, organisms were grown in the presence of paraquat, a redox cycling reagent which penetrates the cytosol, greatly increasing superoxide production there, and which has been shown to penetrate and kill other neisserial organisms (25). The sensitivities of wild-type and sodC mutant meningococci at concentrations up to 200 µM paraquat were similar (data not shown). In conclusion, periplasmic Cu,Zn SOD in N. meningitidis does not appear to confer any additional protection over that afforded by the cytosolic enzyme against the superoxide flux generated in the cytoplasm as a result of normal aerobic respiration, or under conditions of enhanced superoxide flux in the cytosol.
To challenge meningococci with an extracellular source of superoxide, experiments using the X/XO superoxide-generating system were carried out. In a reaction catalyzed by XO, X is converted to urate, generating superoxide in the process. This system also generates H2O2, both directly by two-electron transfer to oxygen and indirectly through the dismutation (spontaneous and iron catalyzed) of superoxide. Both of these species, and products of the reaction between them, are microbicidal. In GC1 broth containing 100 µM X, both wild-type and sodC mutant organisms remained fully viable over the 1-h course of the experiments. However, the toxic oxygen species generated by the addition of 7 mU of XO/ml reduced the viability of both wild-type and sodC mutant phenotypes, the latter much more than the former (approximately a 1,000-fold difference in survival [P < 0.03]) (Fig. 4). These results are consistent with the findings of Schnell and Steinman (42), who, working with C. crescentus, showed that periplasmic Cu,Zn SOD was protective in this system. They observed a difference in survival of as much as 20-fold between wild-type and sodC mutant phenotypes on exposure to X/XO.
|
(ii) In vivo.
To investigate whether the protective role of
Cu,Zn SOD against environmental superoxide is important in the context
of infection, where meningococci are subject to host defenses involving
oxygen free radicals, a mouse model was employed (28, 35).
Although there is no satisfactory model that reproduces natural
meningococcal disease, this system has been of use in distinguishing
between meningococci of high and low virulence (9, 29, 36,
43). Mice were inoculated i.p. with bacteria and iron dextran,
and survival was monitored for 4 days. When an infecting dose of 2 × 106 CFU was used, 25 of 25 animals given the wild type
and 24 of 25 given the sodC mutant died, suggesting that
they were overwhelmed by this number of bacteria. However, a
significant difference in survival (
2 = 4.08;
P < 0.05) was observed between animals given 5 × 105 CFU of wild-type versus sodC mutant
meningococci; the mutant exhibited attenuated virulence. In each case
the whole of the lethal effect was seen by the end of 48 to 60 h
(Fig. 5). Only 6 of 25 animals infected
with wild-type meningococci survived, compared to 14 of 25 infected
with the sodC mutant. Twenty-four hours after infection, at
the time of the second iron dextran injection, the majority of animals
given wild-type MC58 looked ill (immobile, with ruffled fur), whereas
animals infected with the sodC mutant were mainly
recovering. Thus, expression of Cu,Zn SOD is associated with enhanced
early virulence in this model.
|
| |
ACKNOWLEDGMENTS |
|---|
This work was funded by grants to J.S.K. from the Meningitis Research Foundation and the World Health Organization.
K.E.W. and K.L.R.D. contributed equally to this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Molecular Infectious Diseases Group, Department of Paediatrics, Imperial College School of Medicine at St. Mary's Hospital, London W2 1PG, United Kingdom. Phone: (44) 171 886 6220. Fax: (44) 171 886 6284. E-mail s.kroll{at}ic.ac.uk.
Present address: Department of Microbiology, University Hospital,
Queens Medical Centre, Nottingham NG7 2UH, United Kingdom.
Editor: J. G. Cannon
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Archibald, F. S., and M.-N. Duong.
1986.
Superoxide dismutase and oxygen toxicity defenses in the genus Neisseria.
Infect. Immun.
51:631-641 |
| 2. | Beauchamp, C. O., and I. Fridovich. 1971. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal. Biochem. 44:276-287[Medline]. |
| 3. | Beck, B. L., L. B. Tabatabai, and J. E. Mayfield. 1990. A protein isolated from Brucella abortus is a Cu-Zn superoxide dismutase. Biochemistry 29:372-376[Medline]. |
| 4. | Benov, L., L. Y. Chang, B. Day, and I. Fridovich. 1995. Copper, zinc superoxide dismutase in Escherichia coli: periplasmic localization. Arch. Biochem. Biophys. 319:508-511[Medline]. |
| 5. |
Benov, L. T., and I. Fridovich.
1994.
Escherichia coli expresses a copper- and zinc-containing superoxide dismutase.
J. Biol. Chem.
269:25310-25314 |
| 6. | Bordo, D., K. Djinovic, and M. Bolognesi. 1994. Conserved patterns in the Cu,Zn superoxide dismutase family. J. Mol. Biol. 238:366-386[Medline]. |
| 7. |
Bourne, Y.,
S. M. Redford,
H. M. Steinman,
J. R. Lepock,
J. A. Tainer, and E. D. Getzoff.
1996.
Novel dimeric interface and electrostatic recognition in bacterial Cu,Zn superoxide dismutase.
Proc. Natl. Acad. Sci. USA
93:12774-12779 |
| 8. | Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:248-254[Medline]. |
| 9. |
Brener, D.,
I. W. DeVoe, and B. E. Holbein.
1981.
Increased virulence of Neisseria meningitidis after in vitro iron-limited growth at low pH.
Infect. Immun.
33:59-66 |
| 10. |
Broome-Smith, J., and B. Spratt.
1986.
A vector for the construction of translational fusions to TEM -lactamase and the analysis of protein export signals and membrane protein technology.
Gene
49:341-349[Medline].
|
| 11. | Carlioz, A., and D. Touati. 1986. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase essential for aerobic life? EMBO J. 5:623-630[Medline]. |
| 12. | Cartwright, K. 1995. . Meningococcal disease. John Wiley & Sons Ltd., Chichester, United Kingdom. |
| 13. |
Chang, L. E., and S. N. Cohen.
1978.
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.
J. Bacteriol.
134:1141-1156 |
| 14. | Crapo, J. D., J. M. McCord, and I. Fridovich. 1978. Preparation and assay of superoxide dismutases. Methods Enzymol. 53:382-393[Medline]. |
| 15. | Davies, B. J. 1964. Disc electrophoresis. II. Method and application to human serum proteins. Ann. N. Y. Acad. Sci. 121:404-427. |
| 16. | De Groote, M. A., U. A. Ochsner, M. Shiloh, C. Nathan, J. McCord, M. C. Dinauer, and F. C. Fang. 1997. The role of Cu,Zn-superoxide dismutase (SodC) in Salmonella typhimurium pathogenesis, abstr. B-279, p. 77. Abstracts of the 97th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C. |
| 17. | D'mello, R. A., P. R. Langford, and J. S. Kroll. 1997. Role of bacterial Mn-cofactored superoxide dismutase in oxidative stress responses, nasopharyngeal colonization, and sustained bacteremia caused by Haemophilus influenzae type b. Infect. Immun. 65:2700-2706[Abstract]. |
| 18. |
Dunlap, P. V., and H. M. Steinman.
1986.
Strain variation in bacteriocuprein superoxide dismutase from symbiotic Photobacterium leiognathi.
J. Bacteriol.
165:393-398 |
| 19. | Farrant, J. L., A. Sansone, J. R. Canvin, M. J. Pallen, P. R. Langford, T. S. Wallis, G. Dougan, and J. S. Kroll. 1997. Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol. Microbiol. 25:785-796[Medline]. |
| 20. | Gotschlich, E. C. 1976. Unsolved problems in the prevention of meningococcal meningitis, p. 91-102. In R. F. Beers, Jr., and E. G. Bassett (ed.), The role of immunological factors in infections: allergic and autoimmune process. Raven Press, New York, N.Y. |
| 21. | Guibourdenche, M., M. Y. Popoff, and J. Y. Riou. 1986. Deoxyribonucleic acid relatedness among Neisseria gonorrhoeae, N. meningitidis, N. lactamica, N. cinerea and "Neisseria polysaccharea." Ann. Inst. Pasteur Microbiol. 137B(2):177-185. |
| 22. | Halliwell, B., and J. M. C. Gutteridge. 1985. , p. 118-119. Free radicals in biology and medicine Oxford University Press, Oxford, United Kingdom. |
| 23. | Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580[Medline]. |
| 24. |
Hassan, H. M., and I. Fridovich.
1979.
Paraquat and Escherichia coli.
J. Biol. Chem.
254:10846-10852 |
| 25. |
Hassett, D. J.,
B. E. Britigan,
T. Svendsen,
G. M. Rosen, and M. S. Cohen.
1987.
Bacteria form intracellular free radicals in response to paraquat and streptonigrin. Demonstration of the potency of hydroxyl radical.
J. Biol. Chem.
262:13404-13408 |
| 26. | Heyderman, R. S., N. J. Klein, and M. Levin. 1992. Pathophysiology and management of meningococcal septicaemia. Recent Adv. Paediatr. 11:1-18. |
| 27. | Hoke, C., and N. A. Vedros. 1982. Taxonomy of the neisseriae: deoxyribonucleic acid base composition, interspecific transformation, and deoxyribonucleic acid hybridization. Int. J. Syst. Bacteriol. 32:57-66. |
| 28. |
Holbein, B. E.
1981.
Enhancement of Neisseria meningitidis infection in mice by addition of iron bound to transferrin.
Infect. Immun.
34:120-125 |
| 29. | Holbein, B. E. 1981. Differences in virulence for mice between disease and carrier strains of Neisseria meningitidis. Can. J. Microbiol. 27:738-741[Medline]. |
| 30. |
Imlay, K. R. C., and J. A. Imlay.
1996.
Cloning and analysis of sodC, encoding the copper-zinc superoxide dismutase of Escherichia coli.
J. Bacteriol.
178:2564-2571 |
| 31. |
Kroll, J. S.,
P. R. Langford, and B. M. Loynds.
1991.
Copper-zinc superoxide dismutase of Haemophilus influenzae and H. parainfluenzae.
J. Bacteriol.
173:7449-7457 |
| 32. | Kroll, J. S., P. R. Langford, K. E. Wilks, and A. D. Keil. 1995. Bacterial [Cu,Zn]-superoxide dismutase: phylogenetically distinct from the eukaryotic enzyme and not so rare after all! Microbiology 141:2271-2279[Abstract]. |
| 33. | Langford, P. R., B. M. Loynds, and J. S. Kroll. 1992. Copper-zinc superoxide dismutase in Haemophilus species. J. Gen. Microbiol. 138:517-522[Medline]. |
| 34. | Latimer, E., J. Simmers, N. Sriranganathan, R. M. Roop II, G. G. Schurig, and S. M. Boyle. 1992. Brucella abortus deficient in copper/zinc superoxide dismutase is virulent in BALBc mice. Microb. Pathog. 12:105-113[Medline]. |
| 35. | Mackinnon, F. G., A. R. Gorringe, S. G. P. Funnell, and A. Robinson. 1992. Intranasal infection of infant mice with Neisseria meningitidis. Microb. Pathog. 12:415-420[Medline]. |
| 36. |
Masson, L., and B. E. Holbein.
1985.
Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice.
Infect. Immun.
47:465-471 |
| 37. |
McCord, J. M., and I. Fridovich.
1969.
Superoxide dismutase. An enzymatic function for erythrocuprein (hemocuprein).
J. Biol. Chem.
244:6049-6055 |
| 38. |
Nassif, X.,
D. Puaoi, and M. So.
1991.
Transposition of Tn1545- 3 in the pathogenic neisseriae: a genetic tool for mutagenesis.
J. Bacteriol.
173:2147-2154 |
| 39. |
Natvig, D. O.,
K. Imlay,
D. Touati, and R. A. Hallewell.
1987.
Human copper-zinc superoxide dismutase-deficient Escherichia coli mutants.
J. Biol. Chem.
262:14697-14701 |
| 40. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. . Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 41. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 42. |
Schnell, S., and H. M. Steinman.
1995.
Function and stationary-phase induction of periplasmic copper-zinc superoxide dismutase and catalase/peroxidase in Caulobacter crescentus.
J. Bacteriol.
177:5924-5929 |
| 43. |
Schryvers, A. B., and G. C. Gonzalez.
1989.
Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice.
Infect. Immun.
57:2425-2429 |
| 44. | Stabel, T. J., Z. Sha, and J. E. Mayfield. 1994. Periplasmic location of Brucella abortus Cu/Zn superoxide dismutase. Vet. Microbiol. 38:307-314[Medline]. |
| 45. |
Steinman, H. M.
1985.
Bacteriocuprein superoxide dismutases in pseudomonads.
J. Bacteriol.
162:1255-1260 |
| 46. |
Steinman, H. M., and B. Ely.
1990.
Copper-zinc superoxide dismutase of Caulobacter crescentus: cloning, sequencing, and mapping of the gene and periplasmic location of the enzyme.
J. Bacteriol.
172:2901-2910 |
| 47. |
St. John, G., and H. M. Steinman.
1996.
Periplasmic copper-zinc superoxide dismutase of Legionella pneumophila: role in stationary-phase survival.
J. Bacteriol.
178:1578-1584 |
| 48. | Tainer, J. A., E. D. Getzoff, K. M. Beem, J. S. Richardson, and D. C. Richardson. 1982. Determination and analysis of the 2Å structure of bovine copper, zinc superoxide dismutase. J. Mol. Biol. 160:181-217[Medline]. |
| 49. |
Tatum, F. M.,
P. G. Detilleux,
J. M. Sacks, and S. M. Halling.
1992.
Construction of Cu-Zn superoxide dismutase deletion mutants of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice.
Infect. Immun.
60:2863-2869 |
| 50. | Virji, M., H. Kayhty, D. J. P. Ferguson, C. Alexandrescu, J. E. Heckels, and E. R. Moxon. 1991. The role of pili in the interactions of pathogenic Neisseria with cultured human endothelial cells. Mol. Microbiol. 5:1831-1841[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|